Heba Elzahabi
Pharmaceutical Medicinal Chemistry/Faculty of Pharmacy · Al AZHAR University
Research Interests
pharmaceutical medicinal chemistry organic synthetic chemistry biological screening drug design organometallic chemistry
Biography
Heba Elzahabi is a professor in pharmaceutical medicinal chemistry. She received her B. Sc. in 1993 from Cairo University, college of pharmacy, M. Sc. Degree on studying the anticonvulsant activity of some novel diphenic acid derivatives in 1998 from Al-Azhar University, college of pharmacy. She achieved her PhD study (2003) on investigating the anti-inflammatory, analgesic activity of novel quinoxalines. She achieved researches on new anticancer agents e.g. in-vitro study against enzymes involved in cancer, researches in organometallic chemistry to testifying the effect of metal chelation on the therapeutic action, with handling a full thermal analysis of organometallic compounds.
Education
Bachelor of pharmaceutical science Master and PhD of pharmaceutical medicinal chemistry MBA candidate Entrepreneurial thoughts (Babson University)
Recent Scopus Publications
- Antibacterial and anticancer profiling of new benzocaine derivatives: Design, synthesis, and molecular mechanism of action
- Cytotoxicity, docking study of new fluorinated fused pyrimidine scaffold: Thermal and microwave irradiation synthesis
- Design and synthesis of novel tranilast analogs: Docking, antiproliferative evaluation and in-silico screening of TGFβR1 inhibitors
- Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study
- Utility of anthranilic acid and diethylacetylenedicarboxylate for the synthesis of nitrogenous organo/organometallic compounds as urease inhibitors
Links
- ORCID https://orcid.org/0000-0002-7023-6364
- Scopus https://www.scopus.com/authid/detail.uri?authorId=36473171600